PEG-interleukin-2

DB17590InvestigationalProtein Based Therapies

PEG-interleukin-2: Overview.

Also known as
Polyethylene glycol-modified recombinant interleukin-2

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of PEG-interleukin-2, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In